Agios Pharma (AGIO) Tops Q3 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.78), $0.12 better than the analyst estimate of ($1.90). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $10.54 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Blue Owl Credit Income Corp caps Q2 tender offer at 5% of shares
• Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
• Ferrari (RACE) PT Raised to $497 at UBS: Sequential Acceleration Likely in Q2